Literature DB >> 9915553

Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors.

N Zhang1, T F Deuel.   

Abstract

The heparin-binding polypeptide homologs pleiotrophin and midkine are the only known members of a family of secreted growth/differentiation cytokines. Pleiotrophin and midkine are both developmentally regulated and highly conserved among species. They signal a number of physiological functions involved with angiogenesis, neuorogenesis, cell migration, and mesoderm-epithelial interactions. Constitutive expression of pleiotrophin and midkine in responsive cells support their role as "tumor growth factors" and positive regulators of tumor angiogenesis. Widespread deregulation of pleiotrophin and midkine is found in many known human cancers or their derived cell lines, and the molecular targeting of pleiotrophin to block its signaling in tumor cells has limited tumor growth and metastasis in animal models. Elucidating the molecular mechanisms of pleiotrophin and midkine action in tumorgenesis and tumor angiogenesis may lead to the identification of novel targets for tumor therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915553     DOI: 10.1097/00062752-199901000-00008

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  18 in total

Review 1.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C.

Authors:  Harold Pariser; Gonzalo Herradon; Laura Ezquerra; Pablo Perez-Pinera; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

Review 3.  Pancreatic cancer.

Authors:  C Güngör; B T Hofmann; G Wolters-Eisfeld; M Bockhorn
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.

Authors:  Gang Xi; Victoria E Demambro; Susan D'Costa; Shalier K Xia; Zach C Cox; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

5.  Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

Authors:  Jaouhar Mourali; Alan Bénard; Filipe Calheiros Lourenço; Céline Monnet; Catherine Greenland; Christel Moog-Lutz; Claire Racaud-Sultan; Daniel Gonzalez-Dunia; Marc Vigny; Patrick Mehlen; Georges Delsol; Michèle Allouche
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 6.  Multiple system atrophy: cellular and molecular pathology.

Authors:  D J Burn; E Jaros
Journal:  Mol Pathol       Date:  2001-12

Review 7.  Midkine and cytoplasmic maturation of mammalian oocytes in the context of ovarian follicle physiology.

Authors:  Shuntaro Ikeda; Masayasu Yamada
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 8.  Molecular pathways of anxiety revealed by knockout mice.

Authors:  S J Wood; M Toth
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

9.  Dynamic changes of gene expression profiles during postnatal development of the heart in mice.

Authors:  H-W Chen; S-L Yu; W-J Chen; P-C Yang; C-T Chien; H-Y Chou; H-N Li; K Peck; C-H Huang; F-Y Lin; J J W Chen; Y-T Lee
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

10.  Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis.

Authors:  Li-Cheng Dai; Xiang Wang; Xing Yao; Yong-Liang Lu; Jin-Liang Ping; Jian-Fang He
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.